Pfizer may sell animal health business to clear Wyeth merger

Pharmaceutical company Pfizer may shed some of its veterinary drugs business to get the green light from the US Federal Trade Commission for its acquisition of rival Wyeth.

Purchase an approved for publication custom PDF below.

An official PDF provides excellent marketing opportunities, enabling you to post the article online, make reprints and distribute under the GCR brand.

• $200 (USD)
Add Amount: 1 2 3 4 5 6 7 8 9 10
• Add to Basket